The success of Arcturus Therapeutics was attributed to strategic timing and unique trial opportunities in Vietnam and Japan. The emergence of samRNA technology amid the Covid-19 pandemic offers promising advancements but faces challenges such as efficacy, safety concerns, and technical hurdles.